Wells Fargo’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.9M Sell
118,631
-10,076
-8% -$2.53M ﹤0.01% 1371
2025
Q4
$36.6M Sell
128,707
-28,330
-18% -$8.86M 0.01% 1110
2025
Q3
$48.5M Buy
157,037
+37,762
+32% +$11.8M 0.01% 940
2025
Q2
$37.5M Sell
119,275
-28,200
-19% -$8.14M 0.01% 1012
2025
Q1
$38.7M Sell
147,475
-6,915
-4% -$1.87M 0.01% 935
2024
Q4
$40.3M Sell
154,390
-8,358
-5% -$2.1M 0.01% 926
2024
Q3
$37.9M Buy
162,748
+20,915
+15% +$4.29M 0.01% 926
2024
Q2
$28.6M Sell
141,833
-1,688
-1% -$304K 0.01% 1027
2024
Q1
$24.6M Buy
143,521
+21,495
+18% +$4.01M 0.01% 1109
2023
Q4
$26.5M Sell
122,026
-14,128
-10% -$2.42M 0.01% 1011
2023
Q3
$21.7M Sell
136,154
-17,858
-12% -$4M 0.01% 1039
2023
Q2
$44.4M Buy
154,012
+7,349
+5% +$2.23M 0.01% 757
2023
Q1
$46.8M Buy
146,663
+13,604
+10% +$4.03M 0.01% 717
2022
Q4
$39.2M Buy
133,059
+2,400
+2% +$662K 0.01% 775
2022
Q3
$30M Sell
130,659
-1,922
-1% -$481K 0.01% 867
2022
Q2
$28.9M Sell
132,581
-63,884
-33% -$14.5M 0.01% 940
2022
Q1
$52.3M Buy
196,465
+95,394
+94% +$23.4M 0.01% 758
2021
Q4
$26.9M Sell
101,071
-886,601
-90% -$257M 0.01% 1131
2021
Q3
$281M Buy
987,672
+4,615
+0.5% +$1.32M 0.06% 300
2021
Q2
$270M Sell
983,057
-16,798
-2% -$4.57M 0.06% 312
2021
Q1
$261M Buy
999,855
+25,178
+3% +$6.74M 0.06% 322
2020
Q4
$249M Sell
974,677
-5,000
-0.5% -$1.24M 0.06% 314
2020
Q3
$232M Buy
979,677
+126,616
+15% +$26.7M 0.06% 291
2020
Q2
$166M Sell
853,061
-177,241
-17% -$33.9M 0.05% 366
2020
Q1
$171M Sell
1,030,302
-96,046
-9% -$17.6M 0.06% 309
2019
Q4
$193M Sell
1,126,348
-391,593
-26% -$65.2M 0.05% 357
2019
Q3
$250M Sell
1,517,941
-31,890
-2% -$4.48M 0.07% 272
2019
Q2
$185M Buy
1,549,831
+455,742
+42% +$46.7M 0.05% 353
2019
Q1
$104M Buy
1,094,089
+218,280
+25% +$18.7M 0.03% 532
2018
Q4
$69.5M Buy
875,809
+718
+0.1% +$60.8K 0.02% 661
2018
Q3
$92.7M Buy
875,091
+157,722
+22% +$14.8M 0.03% 619
2018
Q2
$61.5M Sell
717,369
-28,768
-4% -$2.58M 0.02% 807
2018
Q1
$64.7M Sell
746,137
-5,510
-0.7% -$428K 0.02% 774
2017
Q4
$51.9M Sell
751,647
-91,074
-11% -$5.98M 0.02% 864
2017
Q3
$46.4M Sell
842,721
-319,840
-28% -$17.5M 0.01% 908
2017
Q2
$59.7M Buy
1,162,561
+254,620
+28% +$11.1M 0.02% 776
2017
Q1
$39.1M Buy
907,941
+861,229
+1,844% +$36.9M 0.01% 982
2016
Q4
$1.76M Buy
46,712
+22,844
+96% +$851K ﹤0.01% 3258
2016
Q3
$977K Sell
23,868
-1,687
-7% -$66.7K ﹤0.01% 3507
2016
Q2
$773K Buy
25,555
+1,382
+6% +$43K ﹤0.01% 3653
2016
Q1
$802K Buy
24,173
+3,622
+18% +$114K ﹤0.01% 3548
2015
Q4
$777K Buy
20,551
+3,811
+23% +$128K ﹤0.01% 3635
2015
Q3
$433K Sell
16,740
-84,589
-83% -$2.57M ﹤0.01% 4032
2015
Q2
$3.14M Sell
101,329
-193,280
-66% -$5.7M ﹤0.01% 2756
2015
Q1
$9.82M Sell
294,609
-307,689
-51% -$10.4M ﹤0.01% 1891
2014
Q4
$27.7M Buy
602,298
+219,333
+57% +$9.38M 0.01% 1083
2014
Q3
$14.1M Buy
382,965
+40,777
+12% +$1.49M 0.01% 1498
2014
Q2
$13.6M Buy
342,188
+1,734
+0.5% +$66.6K 0.01% 1581
2014
Q1
$16.1M Sell
340,454
-5,552
-2% -$246K 0.01% 1416
2013
Q4
$12.8M Sell
346,006
-51,176
-13% -$1.89M 0.01% 1543
2013
Q3
$14.4M Sell
397,182
-39,524
-9% -$1.33M 0.01% 1409
2013
Q2
$13.7M Buy
+436,706
New +$12.4M 0.01% 1377

Other funds holding PODD

Wells Fargo's PODD Position: Q1 2026 in Review

Wells Fargo reduced its Insulet (PODD) stake by 7.8% in Q1 2026, selling an estimated $2.53M and leaving 118,631 shares worth $24.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1371.

Wells Fargo first reported a position in PODD in Q2 2013 and has held it in 52 quarters since. The position peaked at $281M in Q3 2021. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Wells Fargo held 118,631 shares of Insulet worth $24.9M as of Q1 2026.
  • Wells Fargo sold 10,076 Insulet shares in Q1 2026, an estimated $2.53M.
  • Insulet made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1371 holding.
  • Wells Fargo first reported a position in Insulet in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Insulet position peaked at $281M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.